Work

The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells

Year: 2015

Type: article

Source: Cell Death and Differentiation

DOI: 10.1038/cdd.2015.7

Authors: S-H Kim, E-J Kim, M Hitomi, S-Y Oh, X Jin, H-M Jeon, S Beck, X Jin, J-K Kim, C G Park, S-Y Chang, J Yin, T Kim, Y-j Jeon, J Song, Y C Lim, J D Lathia, I Nakano, H Kim

Institutions: Korea University, The Ohio State University, Cleveland Clinic, Cleveland Clinic Research, The University of Texas at Austin, National Cancer Center, The University of Texas MD Anderson Cancer Center, Konkuk University, Konkuk University Medical Center, Cleveland Clinic Lerner College of Medicine, Case Comprehensive Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Cancer Society, Brigham and Women's Hospital, Cleveland Clinic, National Research Foundation, Keio University, Korea University, National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G1460795242, Metabolism Informs Intertumoral & Intratumoral Heterogeneity, Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cells, G5334125748, G5919153597, Targeting MELK-mediated EZH2 signaling in glioma stem cells, G7208565621, G82785621, G9000098662, G9000226092, Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas

OpenAlex ID: W2162621700

FWCI: 2.983

Cites: 30

Cited by: 46

Related to: 10